PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 30 filers reported holding PROTARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $333,451 | -30.1% | 199,671 | 0.0% | 0.00% | -33.3% |
Q2 2023 | $477,214 | -23.6% | 199,671 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $624,970 | +16.8% | 199,671 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $535,118 | -9.5% | 199,671 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $591,000 | +1.0% | 199,671 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $585,000 | -42.6% | 199,671 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $1,020,000 | -24.3% | 199,671 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $1,348,000 | -2.5% | 199,671 | 0.0% | 0.01% | +16.7% |
Q3 2021 | $1,382,000 | -28.9% | 199,671 | 0.0% | 0.01% | -33.3% |
Q2 2021 | $1,945,000 | -38.1% | 199,671 | 0.0% | 0.01% | -35.7% |
Q1 2021 | $3,143,000 | -35.0% | 199,671 | 0.0% | 0.01% | -22.2% |
Q4 2020 | $4,834,000 | +43.9% | 199,671 | 0.0% | 0.02% | +38.5% |
Q3 2020 | $3,360,000 | -42.6% | 199,671 | 0.0% | 0.01% | -50.0% |
Q2 2020 | $5,854,000 | – | 199,671 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |